Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2013; 19(40): 6849-6856
Published online Oct 28, 2013. doi: 10.3748/wjg.v19.i40.6849
Published online Oct 28, 2013. doi: 10.3748/wjg.v19.i40.6849
Table 2 Laboratory examination results, portal diameter and splenic area in antiviral and non-antiviral groups during the study (mean ± SD)
Non-antiviral | Antiviral | P value | |
(n = 38) | (n = 79) | ||
GPT (IU/L) | 19.2 ± 53.1 | -28.6 ± 58.8 | < 0.001 |
GOT (IU/L) | 19.9 ± 52.8 | -34.9 ± 86.2 | 0.001 |
TB (mmol/L) | 3.9 ± 9.6 | -3.8 ± 9.5 | 0.009 |
ALB (g/L) | -2.8 ± 5.5 | 1.2 ± 6.1 | 0.003 |
PT (s) | 1.4 ± 2.2 | -0.2 ± 2.1 | 0.001 |
PLT (1012/L) | -18.9 ± 28.8 | -10.3 ± 16.9 | 0.029 |
Diameter of portal vein (mm) | 1.0 ± 0.9 | 0.2 ± 0.8 | < 0.001 |
Splenic section area (cm2) | 8.6 ± 7.2 | 3.6 ± 9.8 | 0.012 |
- Citation: Li CZ, Cheng LF, Li QS, Wang ZQ, Yan JH. Antiviral therapy delays esophageal variceal bleeding in hepatitis B virus-related cirrhosis. World J Gastroenterol 2013; 19(40): 6849-6856
- URL: https://www.wjgnet.com/1007-9327/full/v19/i40/6849.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i40.6849